This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
MGPI vs. DEO: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MGPI vs. DEO: Which Stock Is the Better Value Option?
PEP Q3 Earnings Beat Estimates, Subdued Category Demand Hurt Sales
by Zacks Equity Research
PepsiCo's Q3 sales continue to reflect the impacts of subdued category demand and QFNA recall issues, while earnings gain from stringent productivity measures.
STZ Q2 Earnings Beat, Sales Miss on Soft Wine & Spirits Business
by Zacks Equity Research
Constellation Brands' Q2 results reflect gains from strong shipment and depletion volumes in the beer business, offset by a soft wine & spirits segment.
Diageo Completes Sale of Its Guinness Nigeria Share to Tolaram
by Zacks Equity Research
DEO benefits from its focus on improving productivity, coupled with its diversified footprint. It concludes the sale of its shareholding in Guinness Nigeria PLC to Tolaram.
Diageo Stock Slides 8% YTD: A Buy Opportunity or Time to Exit?
by Zacks Equity Research
DEO faces hurdles from shifting consumer sentiment and high inventory in LAC, while a cautious consumer backdrop impacts its U.S. Spirits segment in North America.
KNBWY or DEO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
KNBWY vs. DEO: Which Stock Is the Better Value Option?
KNBWY or DEO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
KNBWY vs. DEO: Which Stock Is the Better Value Option?
Diageo (DEO) FY24 Earnings & Sales Decline Y/Y on Soft Volume
by Zacks Equity Research
Diageo's (DEO) FY24 results reflect the impacts of soft volume particularly in LAC and North America, which hurt organic sales. Soft operating profit and higher costs hurt the bottom line.
KNBWY vs. DEO: Which Stock Is the Better Value Option?
by Zacks Equity Research
KNBWY vs. DEO: Which Stock Is the Better Value Option?
Will LAC Issues & Inflation Hurt Diageo's (DEO) FY24 Earnings?
by Zacks Equity Research
Diageo's (DEO) FY24 results are likely to reflect negative consumer sentiment and increased inventory levels in LAC, pressured further by escalating input costs.
Diageo (DEO), Tolaram Alliance to Aid Growth in Guinness Nigeria
by Zacks Equity Research
Diageo (DEO) benefits from its focus on improving productivity coupled with its diversified footprint, a solid portfolio of brands, innovation and pricing.
Zacks Industry Outlook AnheuserBusch InBev, Diageo, Constellation Brands, Molson Coors and The Boston Beer
by Zacks Equity Research
AnheuserBusch InBev, Diageo, Constellation Brands, Molson Coors and The Boston Beer have been highlighted in this Industry Outlook article.
5 Stocks in Focus as Alcohol Industry Faces Inflation Wrath
by Rajani Lohia
The Beverages - Alcohol industry continues to be in the doldrums, thanks to commodity cost inflation resulting in higher input and packaging costs, and elevated marketing expenses. Innovation and premiumization place players like BUD, DEO, STZ, TAP and SAM in a favorable spot.
CABGY or DEO: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CABGY vs. DEO: Which Stock Is the Better Value Option?
Here's Why You Should Retain Archer Daniels (ADM) Stock
by Zacks Equity Research
Archer Daniels (ADM) progresses well on its strategic growth pillars. The company is also actively managing productivity and innovation.
Productivity Actions Drive Diageo (DEO) Amid Cost Woes
by Zacks Equity Research
Diageo (DEO) progresses well on its new productivity commitment, targeting productivity savings of $2 billion from fiscal 2025 to 2027. Will this continue to aid its performance amid high costs?
Energizer (ENR) Q2 Earnings Beat Estimates, Sales Dip Y/Y
by Zacks Equity Research
Energizer's (ENR) second-quarter fiscal 2024 sales were lower year over year on soft organic sales and lower sales for the Batteries & Lights segment.
Monster Beverage's (MNST) Q1 Earnings Miss, Sales Rise Y/Y
by Zacks Equity Research
Monster Beverage (MNST) sees strength in its energy drinks category. In addition, the company's expansion strategy bodes well.
Clorox (CLX) Q3 Earnings Beat Estimates, Revenues Down Y/Y
by Zacks Equity Research
Clorox's (CLX) third-quarter fiscal 2024 bottom line benefits from pricing actions and cost-saving initiatives. The company also boasts a solid innovation pipeline.
Archer Daniels (ADM) Q1 Earnings Beat Estimates, Revenues Down
by Zacks Equity Research
Archer Daniels (ADM) reports lower revenues year over year in first-quarter 2024 due to a decline in sales across all segments.
FEMSA (FMX) Q1 Earnings Decline Year Over Year, Revenues Up
by Zacks Equity Research
FEMSA (FMX) posts lower earnings year over year in first-quarter 2024. However, revenues improved 11.3% year over year.
Newell (NWL) Earnings Surpass Estimates in Q1 Sales Dip Y/Y
by Zacks Equity Research
Newell (NWL) reports a sales decline in first-quarter 2024, owing to a core sales drop of 4.7% year over year.
Keurig (KDP) Stock Gains as Q1 Earnings & Sales Top Estimates
by Zacks Equity Research
Keurig's (KDP) Q1 results reflect strong brand momentum, as evident from market share growth across regions and elasticity across most categories. Improved net price realization also aids results.
PepsiCo (PEP) Q1 Earnings & Sales Beat, International Unit Aids
by Zacks Equity Research
PepsiCo's (PEP) Q1 results reflect strong momentum across its international business, driven by at least high-single-digit organic revenue growth in all its international regions.
Zacks Industry Outlook Highlights AnheuserBusch InBev, Diageo Plc, Constellation Brands Inc., Brown-Forman and Molson Coors
by Zacks Equity Research
AnheuserBusch InBev, Diageo Plc, Constellation Brands Inc., Brown-Forman and Molson Coors are part of the Zacks Industry Outlook article.